ESWL is one of the treatment modalities for kidney stones smaller than 2 cm. However, not all ESWL treatments are successful. The success rate has been reported to be between 50% to 87%, depending on various factors.
Introduction
Urolithiasis is a problem that has confronted by clinicians since the time of Hippocrates and the prevalence of urolithiasis is approximately 4 to 15 percent in general population and the estimated lifetime risk of developing a kidney stone is about 12 percent for white males. Approximately 50 percent of patient with urinary calculi have a recurrence within 10 years. 1 Renal stones are common approximately 50% of patient between the ages of 30 to 50 years. The male-female ratio is 4:3. Calculi smaller than 0.5 cm, pass spontaneously unless they are impacted. Any surgical intervention carries risk of complication and needless intervention should be avoided. Small renal calculi may cause symptoms by obstructing a calyx or acting as a focus for secondary infection. However most can be safely observed until they pass. 2 The development of endourological and extracorporeal lithotripsy techniques led to an increasing number of options for the management of renal calculi. Each of the methods available needs to be evaluated in term of its stone clearance rate, potential morbidity and cost effectiveness. Extracorporeal shock wave lithotripsy (ESWL) is an effective, well established method for treatment of renal calculi. 3, 4 Chaussy et al was the first to report the clinical application of shock wave lithotripsy in the management of kidney stones and then the management of nephrolithiasis has undergone a complete revolution. 5 For most renal stone smaller than 20mm, ESWL is the most effective primary treatment modality. ESWL is effective in all calyceal locations which are less than 20mm. The success rate of ESWL has been depending on stone size, stone location, stone number, renal morphology, congenital anomalies and stone composition. 4 Stone radio density, a useful parameter for predicting outcome of ESWL for stone d"20mm. Mina suggests that for stones <20mm within renal pelvis, the value of radiographic appearance of a stone alone in determining treatment outcome on the doli machine is somewhat limited. 6 There seems to be tendency for a worse outcome for stone 11to 20mm that have a radio density greater than 12th rib. 7 Treatment outcome after lithotripsy depends on several factors. The type of lithotriptor, stone characteristics (number, size, composition and location), patient characteristics and renal anatomy and function are important factors for determining treatment characteristics and outcome. Although the role of shock wave lithotripsy for management of lower pole nephrolithiasis has been questioned in some studies, Overall stone free rates after ESWL vary from 50% to 87%, depending on many factors affecting the overall success rate. 1, 8 On the other hand, shock wave lithotripsy is not without complications and renal trauma from treatment in time may lead to hypertension and renal insufficiency. Factors associated with increased renal damage due to shock wave lithotripsy include high shock wave number & energy. 9
Materials & Method
This hospital based prospective study was conducted on the patients with renal stone (d" 20 mm), in OPD basis in the department of Urology, NIKDU, Dhaka from July 2015 to June 2016. All patients were evaluated by detailed history, physical examination and some investigations. Urinalysis, urine culture and sensitivity, complete blood count (CBC), blood urea nitrogen (BUN), serum Creatinine, coagulation profile and plain X-Ray KUB region, ultrasonography of KUB region, IVU or Non contrast CT Scan of KUB region were done. Patient with documented urinary tract infection were treated with appropriate antibiotic before surgery. Inclusion criteria were patients with renal stones attended at the outpatient department as well as admitted in NIKDU-who are selected for ESWL; Age e"18 years irrespective of sex and BMI; Size of stone will be >5mm or d" 20mm (largest diameter of stone) irrespective of site, laterality, number (single or multiple) and stone composition. Exclusion criteria were age <18 years; patient with ureteric stricture, coagulopathy, nonfunctioning kidney and congenital anomalies of kidney and urinary tract; stone size >20mm; recurrent stones; physical disfigurement eg. Kyphosis, Scoliosis, Lordosis; Spina bifida and spinal cord injury; pregnant women. Patients, selected for ESWL according to inclusion and exclusion criteria, underwent ESWL using the MODULITH SLX-F2 (STORZ, Switzerland). All the patients were nothing per oral from morning and were given intravenous fluid with diclofenac sodium suppository 30 minutes before ESWL. In a single session, maximum of 3000 shock waves were given. Repeated sessions of ESWL were given for an incomplete fragmented calculus after 3 weeks, highest upto 3 sessions.
The patients were termed as ESWL failure when no fragmentation or incomplete fragmentation found after three sessions. Patients were evaluated for stone clearance, time to stone clearance, number of ESWL sessions, pain intensity, incidence of steinstrasse, and any side effects at 1, 2, and 3 months. Visual analogue scale was used to measure the pain intensity.
Treatment success was defined as a complete stone clearance or clinically presence of insignificant residual fragments (CIRFs) (Stone Size < 5mm). Failure was defined as presence of significant residual fragment (SRFs) after 3rd month.
Statistical analysis was done with the data of all 96 patients from the master data sheet. The success rate was correlated with characteristics of the patients and stone feature with chi square test by using SPSS program version 22. A p value <0.05 was considered statistically significant.
Results
At 3 months follow-up of 96 cases complete stone free were observed in 68 patients (70.8%), clinically insignificant residual fragments (CIRFs) were observed in patients 16(16.7%) & significant residual fragments (SRFs) were observed in 12 patients (12.5%). All the complications were managed conservatively according to standard protocol. No complications were encountered in 84 patients (87.5%).
Discussion:
At 3-months follow-up, the overall success rate was 87.5%. This result was matching with some similar previous studies that reported stone free rates were 75-85% for treatment of renal stones by ESWL. 1, 4, 10 This study examined only four factors that had a significant impact on the success rate namely stone size, site, number of stone & BMI of the patient. Other factors like age, sex & radiodensity had no significant impact on the success rate.
In this study, stone size was a significant predictor of ESWL outcome. The success rate for stones <15mm was 93.6%, while it was 75.8% for stone for >15mm (p=0.011). AI-Ansari et al. did a prospective study under 427 patients with single or multiple stones (<30mm) underwent ESWL monotherapy using SL20 lithotriptor. 4 At 3-months follow-up, the overall success rate was 78%. There 10 prognostic factors were studied, 5 had a significant impact on the success rate namely renal morphology, congenital anomalies, stone size, stone site and number stone treated stones, other factors including age, sex, nationality, stone nature and ureteric stenting had no significant impact on the success rate.
In this study, as in others stone size had a significant predictive impact as factor of ESWL outcome. 3, 4, 5, 11 In another study, Lalak et al. evaluated the outcome of ESWL of 500 renal calculi using the dornier compact delta lithotripter. 10 Here the authors found the overall stone free rate was 66%, while <10mm in size was 76% at 6 months follow-up. For 10-20mm stones, the success rate was 66%, while the rate for stones >20mm in size was 47%.
Here the authors did not recommend ESWL as primary therapy for stones >20mm in size. 10 In the present study, the success for stones located in the renal pelvis, upper, middle and lower calyces were 95.50%, 100%, 78.6% & 75.0% respectively (p=0.019). This finding was supported by similar previous studies, where for upper and lower calyceal stones free rate ranges from 90% to 70% respectively, whereas that for lower calyceal and multiple site stones ranges from 70% to 50% respectively. All the studies had shown that better stone clearance rate were in the renal pelvis, upper, & middle calyx than stone in lower calyx. 1, 4, 8, 12 In this study, the success rate for stones located in the lower calyx was 75%. This result is in agreement with a study done by Chen who evaluated the impact of radiological anatomy as predictive factors of lower calyceal stone after ESWL. 13 Here 112 patients with a solitary lower calyceal stone measuring 20mm or less in size were enrolled in that retrospective study. Pretreatment IVU was reviewed for measuring the anatomical predictors, such as lower pole infundibular length (IL), infundibular width (IW) and infundibulopelvic angle (IPA), while the stone location and size were determined on plain abdominal X-ray. All treated with Siemens Lithostar Plus lithotriptor and were followedup for 3-months. Three months after ESWL, only 49(43.7%) patients were stone free. Under multivariate analysis with logistic regression, smaller stone size (10mm or less, p=0.005) and greater IW (4mm or more, 0.029) were significant favorable predictors for better stone clearance. The authors concluded, in addition to the influence of stone size, lower pole anatomy especially IW, had a significant impact on stone clearance for lower calyceal stone after ESWL, that was similar with other studies. 14, 15 In the present study, stone number had a significant impact on stone clearance by ESWL. The success rate for single stone was 90. Lithotriptor. The radiodensity was compared to ipsilateral 12 th rib. Following after 3 months follow-up they declared that there was no corelation between stone radiodensity and stone composition. For stone <10mm within renal pelvis, the SFRs were similar (71-74%) regardless of stone radiodensity. For stone between 11 to 20mm, the SFR was 60%, if the stone had a radiodensity >12 th rib compared to a SFR of 71%, if the stone radiodensity was <12 th rib. However, these differences in SRFs were not statistically significant. 6 In this study, we also had shown that, success rate was gradually decreasing with increasing the radiodensity of stone, but it was not statistically significant (p=0.128).
In the present study, success rate was significantly higher (86%) in patients with BMI 19 to 24 compared to BMI 24 to 27 (57%). This result was also matching with Ackermann et al. who stated that BMI influences the outcome of ESWL. They found that body mass index (BMI) and stone number were the only significant predictors. The authors stated that the best chance of success for ESWL was found in patients with BMI 20 to 28. 16 But Robert et al. found patients with a BMI >25 had a worse outcome after ESWL that matched with present study. 17
Conclusion
The overall success rate of ESWL using Stortz Modulith SLX-F2 Lithotriptor for treatment of renal stones was 87.5%. The success rate gradually decreased in relation to increasing the size of the stone. But it was higher in the upper calyx pelvis and middle calyx than in the lower calyx and multiple sites of kidney. Success rate was higher for patient BMI <24. Repeated sessions were needed in 53.1% and overall complication rate was 12.5%. Factors that significantly affected the success rate included stone size, stone location, multiple stones and patients BMI.
